Serological detection of disease activity in SLE (Q44168826)

30 November 2017

title

Serological detection of disease activity in SLE (English)

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

18 October 2022

author name string

Danao-Camara TC

3

1 reference

30 November 2017

J. D. Clough

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1633636

18 October 2022

B. P. Barna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1633636

18 October 2022

T. C. Danao-Camara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1633636

18 October 2022

R. K. Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1633636

18 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1633636

18 October 2022

publication date

1 June 1992

1 reference

full work available at URL

30 November 2017

https://api.elsevier.com/content/article/PII:000991209290315J?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

https://api.elsevier.com/content/article/PII:000991209290315J?httpAccept=text/plain

18 October 2022

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

18 October 2022

published in

Clinical Biochemistry

1 reference

30 November 2017

volume

25

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

201-208

1 reference

Immunologic factors and clinical activity in systemic lupus erythematosus

30 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Serological tests in the assessment of disease activity in systemic lupus erythematosus

18 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Monitoring of systemic lupus

18 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus.

18 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Useful laboratory measurements in the management of systemic lupus erythematosus

18 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus

18 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity

18 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease

18 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation

18 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Soluble interleukin-2 receptors in systemic lupus erythematosus

18 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus

18 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

The soluble interleukin-2 receptor in rheumatic disease

18 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus

18 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Effectiveness of testing for anti-DNA and the complement components iC3b, Bb, and C4 in the assessment of activity of systemic lupus erythematosus

18 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

The 1982 revised criteria for the classification of systemic lupus erythematosus

18 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Weighted criteria for the diagnosis of systemic lupus erythematosus.

18 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

18 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

New approaches to clinical pathologic correlation in lupus nephritis

18 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Antibodies against nuclear antigens: association with lupus nephritis

18 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes

18 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Expression of interleukin 2 receptors on activated human B cells

18 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac

18 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro

18 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

SIGNIFICANCE OF ANTIBODY TO DNA IN SYSTEMIC LUPUS ERYTHEMATOSUS

18 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease

18 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Immunological studies concerning the nephritis of systemic lupus erythematosus

18 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Circulating DNA-antibodies in systemic lupus erythematosus

18 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis

18 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features

18 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

18 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course

18 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis

18 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans.

18 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0009-9120(92)90315-J

18 October 2022

Identifiers

1 reference

30 November 2017

1 reference